ReShape Lifesciences Inc.
RSLS
$0.63
-$0.0055-0.87%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 743.00K | 1.05M | 2.38M | 4.46M | 1.45M |
| Total Receivables | 1.34M | 1.38M | 1.57M | 1.66M | 2.15M |
| Inventory | 2.93M | 3.25M | 3.47M | 3.74M | 3.20M |
| Prepaid Expenses | 161.00K | 244.00K | 303.00K | 198.00K | 361.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 156.00K | 162.00K | 180.00K | 239.00K | 232.00K |
| Total Current Assets | 5.34M | 6.09M | 7.90M | 10.30M | 7.40M |
|
|
|||||
| Total Current Assets | 5.34M | 6.09M | 7.90M | 10.30M | 7.40M |
| Net Property, Plant & Equipment | 220.00K | 250.00K | 280.00K | 310.00K | 344.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 57.00K | 56.00K | 56.00K | 57.00K | 84.00K |
| Total Assets | 5.62M | 6.39M | 8.23M | 10.66M | 7.83M |
|
|
|||||
| Total Accounts Payable | 2.11M | 1.03M | 1.31M | 1.69M | 1.46M |
| Total Accrued Expenses | 871.00K | 1.07M | 979.00K | 856.00K | 1.52M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 114.00K | 113.00K | 112.00K | 111.00K | 110.00K |
| Total Finance Division Other Current Liabilities | 935.00K | 991.00K | 1.11M | 1.12M | 1.38M |
| Total Other Current Liabilities | 935.00K | 991.00K | 1.11M | 1.12M | 1.38M |
| Total Current Liabilities | 4.03M | 3.20M | 3.52M | 3.78M | 4.47M |
|
|
|||||
| Total Current Liabilities | 4.03M | 3.20M | 3.52M | 3.78M | 4.47M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 77.00K | 103.00K | 127.00K | 151.00K | 175.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 26.00K | 54.00K | 51.00K | 72.00K | 100.00K |
| Total Liabilities | 4.13M | 3.36M | 3.70M | 4.00M | 4.74M |
|
|
|||||
| Common Stock & APIC | 642.52M | 642.49M | 642.40M | 642.33M | 637.05M |
| Retained Earnings | -640.94M | -639.36M | -637.77M | -635.57M | -633.88M |
| Treasury Stock & Other | -88.00K | -89.00K | -96.00K | -88.00K | -94.00K |
| Total Common Equity | 1.49M | 3.04M | 4.53M | 6.66M | 3.08M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.49M | 3.04M | 4.53M | 6.66M | 3.08M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.49M | 3.04M | 4.53M | 6.66M | 3.08M |
|
|
|||||
